U.S. FDA approves Lexicon Pharma’s drug for heart failure

The U.S. Food and Drug Administration (FDA) has approved Lexicon Pharmaceuticals Inc’s drug for a broad treatment of heart failure, including in adult patients with type 2 diabetes, the company said on Friday. Shares of the company rose 13% in extended trading. The oral drug, sotagliflozin…
Read More

Get A FREE Copy Of My Special Report
“Can Your Retirement Survive” Today!
There's Absolutely $0 Cost To You!
We Even Pay For Shipping & Handling!

This post contains affiliate links. If you use these links to buy something we may earn a commission. Thanks.”

You May Also Like